BREAST IMPLANT LIABILITY SETTLEMENT MAXIMUM AWARD LOWERED TO $250,000; 190,000 WOMEN ELIGIBLE FOR REVISED PACT APPROVED BY BOARDS OF BAXTER, BMS, 3M
This article was originally published in The Gray Sheet
Executive Summary
A breast implant liability settlement plan that would award up to $250,000 on a per-patient basis has been approved by the boards of defendants Bristol-Myers Squibb, 3M and Baxter, the U.S. District Court of Alabama reported in a Nov. 13 recorded statement. The maximum compensation under the offer is lower than the amount outlined in an initial version announced by the court in October.